Assessment and Classification of Disease Prognosis
Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months.
Date Reviewed: April 27, 2015
Do Not Support
Group/Practice
Individual Clinician
Measure Info
MIPS 179CMS 179
Measure Type:
Process
Measure Steward:
American College of Rheumatology
Clinical Topic Area:
Rheumatoid Arthritis
Care Setting:
Outpatient
Data Source:
Registry
ACP does not support PQRS 179: “Assessment and Classification of Disease Prognosis.” ACP does not support this measure because there is no evidence supporting annual frequency or describing appropriate frequency for assessment or classification of disease prognosis. Additionally, it seems unnecessary to reassess prognosis annually if a poor prognosis has been established based on factors that will not change such as high titer anti-citric citrullinated peptide (anti-CCP) antibodies, rheumatoid factor (RF) or radiographic erosions.